Godelieve Tytgat

15PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersPeripheral nervous systemGene and molecular therapyMedical biochemistry - nucleic acidsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Mar 12, 2026
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Yvette A H Matser, André B P van Kuilenburg, Atia Samim

|Jan 28, 2026
Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.

Rixt S Bruinsma, Wendy W J de Leng, Marta F Fiocco

|Dec 18, 2025
Minimal Residual Disease Detection in Peripheral Blood of Patients With High-Risk Neuroblastoma Correlates With Outcome in the International GPOH-DCOG Prospective Validation Study.

Nina U Gelineau, Lieke M J van Zogchel, Boris De Carolis

|Apr 02, 2025
SUV normalisation and reference tissue selection for [1⁸F]mFBG PET-CT in paediatric and adult patients.

Atia Samim, Diederik P D Suurd, Rob van Rooij

|Feb 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Yvette A H Matser, Atia Samim, Marta Fiocco

Pageof 3

Frequent Collaborators

7 joint publications

Max M van Noesel

5 joint publications

Karin P S Langenberg

5 joint publications

Yvette Matser

5 joint publications

Marta Fiocco